- Home
- NBTX vs TRIP Comparison
NBTX vs TRIP Comparison
Compare NBTX & TRIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NBTX | TRIP |
|---|---|---|
| Founded | 2003 | 2000 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.3B |
| IPO Year | 2018 | 2011 |
Fundamental Metrics
Financial Performance| Metric | NBTX | TRIP |
|---|---|---|
| Price | $31.80 | $11.27 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 13 |
| Target Price | ★ $36.00 | $14.58 |
| AVG Volume (30 Days) | 44.1K | ★ 4.0M |
| Earning Date | 03-31-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 675.00 |
| EPS | N/A | ★ 0.31 |
| Revenue | N/A | ★ $1,556,000,000.00 |
| Revenue This Year | $59.10 | $3.33 |
| Revenue Next Year | N/A | $5.12 |
| P/E Ratio | ★ N/A | $36.31 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.12 | $9.01 |
| 52 Week High | $41.89 | $20.16 |
Technical Indicators
Market Signals| Indicator | NBTX | TRIP |
|---|---|---|
| Relative Strength Index (RSI) | 54.26 | 60.94 |
| Support Level | $20.11 | $9.36 |
| Resistance Level | $34.66 | $15.37 |
| Average True Range (ATR) | 1.73 | 0.51 |
| MACD | -0.07 | 0.15 |
| Stochastic Oscillator | 61.54 | 89.78 |
Price Performance
Historical ComparisonAbout NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About TRIP TripAdvisor Inc.
Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on several million accommodations, restaurants, experiences, airlines, and cruises. In 2025, 42% of revenue came from the company's core Hotel and Other segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 46% of revenue in 2025, and TheFork, its dining brand, represented 12% of sales.